Scanner logic
Why this stock appeared
AUROPHARMA appeared because the stored NiftyScanner scan found a market-behaviour observation on 2026-09-03. The scanner review is based on multi-year technical price history, recent daily behaviour, participation, liquidity, relative movement, and post-observation tracking fields before public context is attached. This page labels it as a delivery participation observation, meaning the public page is describing participation-style behaviour from the scanner, not a standalone news trigger.
After the scanner observation, NiftyScanner checks public news and corporate-event context to help readers study what else was visible around the same market day. That context is an explanation layer, not a trading instruction.
Public news and event check
Recent market observations for AUROPHARMA highlight three significant corporate and regulatory events within the last 30 days. The company received final US FDA approval for Tofacitinib, a key pipeline expansion. Additionally, the US FTC cleared the $250 million acquisition of Lannett Company, resolving regulatory hurdles for a major strategic deal. The inauguration of the TheraNym facility further underscores opera...